Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioma × Minocycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

cyclopia sequence 13 Carcinoma, Non-Small-Cell Lung 4 Multiple Myeloma 3 Lung Neoplasms 3 Breast Neoplasms 3 Pain 2 Neoplasms, Plasma Cell 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Thromboembolism 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Sleepiness 1 Sezary Syndrome 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Cognitive Complications 1 Peripheral Nervous System Diseases 1 Peptic Ulcer 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Parasomnias 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1

Interventions

Temozolomide 140 Bevacizumab 63 Radiotherapy 54 Magnetic Resonance Spectroscopy 52 Irinotecan 27 Carboplatin 23 Surgical Procedures, Operative 18 Radiation 18 Carmustine 18 Specimen Handling 17 Nivolumab 16 Lomustine 15 Biopsy 15 Aminolevulinic Acid 15 pembrolizumab 12 Radiotherapy, Intensity-Modulated 12 Cyclophosphamide 12 trametinib 11 Topotecan 11 Radiosurgery 11 Erlotinib Hydrochloride 11 fluorodopa F 18 9 IL13-PE38 9 Everolimus 9 ribociclib 8 dabrafenib 8 X-Rays 8 Imatinib Mesylate 8 Filgrastim 8 Etoposide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01580969 2019-08-16

RAMBO

University of Utah

Phase 1/2 Completed

22 enrolled 18 charts

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡